TY - JOUR
T1 - Antihypertensive drugs in COVID-19 infection
AU - Pinto-Sietsma, Sara-Joan
AU - Flossdorf, Michael
AU - Buchholz, Veit R
AU - Offerhaus, Joost
AU - Bleijendaal, Hidde
AU - Beudel, Martijn
AU - Volders, Paul G A
AU - Ter Bekke, Rachel M A
AU - Dormans, Tom
AU - Zwetsloot, Peter-Paul
AU - de Jager, Peter
AU - Massberg, Steffen
AU - Rämer, Patrick
AU - Wendtner, Clemens
AU - Hoffmann, Ellen
AU - Rothe, Kathrin
AU - Feihl, Susanne
AU - Kessler, Thorsten
AU - Pinto, Yigal M
AU - Schunkert, Heribert
PY - 2020/11/1
Y1 - 2020/11/1
KW - Adrenergic beta-Antagonists/administration & dosage
KW - Angiotensin Receptor Antagonists/administration & dosage
KW - Angiotensin-Converting Enzyme Inhibitors/administration & dosage
KW - Antihypertensive Agents/administration & dosage
KW - COVID-19
KW - Calcium Channel Blockers/administration & dosage
KW - Coronavirus Infections/diagnosis
KW - Diuretics/administration & dosage
KW - Drug Administration Schedule
KW - Germany
KW - Hospitalization
KW - Humans
KW - Hypertension/diagnosis
KW - Netherlands
KW - Pandemics
KW - Pneumonia, Viral/diagnosis
KW - Protective Factors
KW - Risk Factors
KW - Treatment Outcome
U2 - 10.1093/ehjcvp/pvaa058
DO - 10.1093/ehjcvp/pvaa058
M3 - Article
C2 - 32501477
SN - 2055-6837
VL - 6
SP - 415
EP - 416
JO - European heart journal - Cardiovascular pharmacotherapy
JF - European heart journal - Cardiovascular pharmacotherapy
IS - 6
ER -